Key Metrics
CiteScore 

2.1
H-Index 

29
SJR 

Q3Hematology

SNIP 

0.67
Recommended pre-submission checks
Powered by 

Topics Covered on Blood Research
Blood Research Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | KOREAN SOC HEMATOLOGY |
| Language | English |
| Frequency | Quarterly |
| General Details |
View less
Planning to publish in Blood Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Blood Research
A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy.
- 19 May 2026
- Blood research
Dynamic, anthracycline-induced chromatin alterations enable ALDH1 expression as a mechanism of inducible leukemia resistance development.
- 13 May 2026
- Blood research
Exploring CD79b, LC3, and TERT expression in NON-GCB DLBCL: markers associated with Rituximab-Cyclophosphamide-Doxorubicin-Vincristin-Prednisone treatment response
- 11 May 2026
- Blood Research
Enlarged splenic volume predicts poor survival and is associated with inflammatory imbalance in patients with diffuse large B-cell lymphoma.
- 8 May 2026
- Blood research
Deregulation of stemness and senescence genes in bone marrow mesenchymal stem cells of multiple myeloma: implications for therapeutic approaches.
- 7 May 2026
- Blood research
Checkpoint inhibitor-induced hematologic immune-related adverse events and their association with disease recurrence in hematolymphoid malignancies: a clinical perspective.
- 6 May 2026
- Blood research
A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy.
- 19 May 2026
- Blood research
Dynamic, anthracycline-induced chromatin alterations enable ALDH1 expression as a mechanism of inducible leukemia resistance development.
- 13 May 2026
- Blood research
Exploring CD79b, LC3, and TERT expression in NON-GCB DLBCL: markers associated with Rituximab-Cyclophosphamide-Doxorubicin-Vincristin-Prednisone treatment response
- 11 May 2026
- Blood Research
Enlarged splenic volume predicts poor survival and is associated with inflammatory imbalance in patients with diffuse large B-cell lymphoma.
- 8 May 2026
- Blood research
Deregulation of stemness and senescence genes in bone marrow mesenchymal stem cells of multiple myeloma: implications for therapeutic approaches.
- 7 May 2026
- Blood research
Checkpoint inhibitor-induced hematologic immune-related adverse events and their association with disease recurrence in hematolymphoid malignancies: a clinical perspective.
- 6 May 2026
- Blood research